Markers associated with endothelial dysfunction, such as von Willebrand factor antigen, soluble P-selectin, and thrombomodulin, hold promise as indicators of endothelial injury and coagulation abnormalities in COVID-19. This evidence concerns the gene THBD and COVID-19.